Research Article
CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF
Table 1
Baseline demographics.
| Characteristics | Values |
| Total patients | 16 (100%) | Male | 10 (63%) | Age (years) | | LVEF (%) | | LVEDd (cm) | | QRS (ms) | | Ischemic cardiomyopathy | 11 (69%) | Impaired renal function (SCr > 1.5 mg/dL) | 10 (63%) | Beta blockers | 10 (63%) | Ace-inhibitors | 10 (63%) | Angiotensin receptor blockers | 2 (12%) | Intravenous diuretics | 16 (100%) | Intravenous inotropes | 13 (81%) | Dobutamine | 12 (75%) | Milrinone | 7 (44%) | Dopamine | 1 (6%) | Nesiritide | 3 (19%) |
|
|